Article: ATROVENT NASAL SPRAY IS THE FIRST MEDICATION IN A NEW CLASS OF NASAL SPRAYS TO RELIEVE A RUNNY NOSE

 
  Relief is Here for Millions Who Suffer from 
 Runny Nose Due to Allergies and Colds 

RIDGEFIELD, Conn., Feb. 1 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals today issued the following:

Atrovent(R) (ipratropium bromide) Nasal Spray today became available as the first medication in a new class of nasal sprays to relieve runny noses (rhinorrhea) associated with year-round allergies, and nonallergic reactions (for which there is no known allergic cause), as well as the common cold. Atrovent Nasal Spray comes in two strengths: 0.3% for the runny nose associated with the allergic and nonallergic conditions, and .06% for the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!